Search details
1.
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
Nature
; 603(7903): 942-948, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35322232
2.
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
N Engl J Med
; 386(5): 449-462, 2022 02 03.
Article
in English
| MEDLINE | ID: mdl-35108470
3.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
N Engl J Med
; 384(13): 1191-1203, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33789008
4.
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.
Future Oncol
; 19(11): 739-752, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36919706
5.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet
; 398(10294): 27-40, 2021 07 03.
Article
in English
| MEDLINE | ID: mdl-34102137
6.
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649.
J Clin Oncol
; 41(35): 5388-5399, 2023 Dec 10.
Article
in English
| MEDLINE | ID: mdl-37713657
7.
Direct measure of fluorescence intensity for efficient receptor-binding assay: conjugates of ethinylcarboxyestradiol and 5(and 6)-carboxyfluorescein via alpha, omega-diaminoalkanes as a tracer for estrogen receptor.
J Biochem
; 143(6): 781-92, 2008 Jun.
Article
in English
| MEDLINE | ID: mdl-18316331
8.
Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition.
Anticancer Res
; 23(5A): 3639-50, 2003.
Article
in English
| MEDLINE | ID: mdl-14666659
Results
1 -
8
de 8
1
Next >
>>